👍-To The Moon - Tiger Brokers Online Investing Community - To The Moon

Like
Comment
Favorite

6f1a6f45
2022-11-29

👍

《新股消息》3D MEDICINES-B(01244.HK)今起招股一手入场费13,252.23元

生物医药公司3D MEDICINES-B公布招股详情，拟全球发售1,635万股，香港公开发售占一成，国际发售占九成。招股价介乎每股22.96至26.24元。每手500股计，一手入场费13,252.23元。该股今日起招股，下周三中午截止，预期将于12月15日挂牌。公司上市引入4名基石投资者，包括徐州经开区(香港)、Harvest、TradArt Investment SP及Mobilewise，合共认购2.35亿元公司股份。

《新股消息》3D MEDICINES-B(01244.HK)今起招股一手入场费13,252.23元

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Like

Report

Comment

Top
Latest

empty

No comments yet

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":620870130,"tweetId":"620870130","gmtCreate":1669690916322,"gmtModify":1676538224016,"author":{"id":4130472326487360,"idStr":"4130472326487360","authorId":4130472326487360,"authorIdStr":"4130472326487360","name":"6f1a6f45","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":3,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>👍</p></body></html>","htmlText":"<html><head></head><body><p>👍</p></body></html>","text":"👍","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/620870130","repostId":2287545465,"repostType":2,"repost":{"id":"2287545465","kind":"news","pubTimestamp":1669681671,"share":"https://www.laohu8.com/m/news/2287545465?lang=&edition=full","pubTime":"2022-11-29 08:27","market":"us","language":"zh","title":"《新股消息》3D MEDICINES-B(01244.HK)今起招股 一手入场费13,252.23元","url":"https://stock-news.laohu8.com/highlight/detail?id=2287545465","media":"AAFN","summary":"生物医药公司3D MEDICINES-B公布招股详情，拟全球发售1,635万股，香港公开发售占一成，国际发售占九成。招股价介乎每股22.96至26.24元。每手500股计，一手入场费13,252.23元。该股今日起招股，下周三中午截止，预期将于12月15日挂牌。公司上市引入4名基石投资者，包括徐州经开区(香港)、Harvest、TradArt Investment SP及Mobilewise，合共认购2.35亿元公司股份。","content":"<html><body><p>生物医药公司3D MEDICINES-B(01244.HK)公布招股详情，拟全球发售1,635万股，香港公开发售占一成，国际发售占九成。招股价介乎每股22.96至26.24元。每手500股计，一手入场费13,252.23元。该股今日(11月29日)起招股，下周三(12月7日)中午截止，预期将于12月15日挂牌。联席保荐人为中金及<a href=\"https://laohu8.com/S/601066\">中信建投</a>国际。公司上市引入4名基石投资者，包括徐州经开区(香港)、Harvest、TradArt Investment SP及Mobilewise，合共认购2.35亿元公司股份。如以招股价中位数24.6元计，公司上市料净集资约2.45亿元，当中约90%主要用于产品和候选药物的研发、监管备案及商业化；约10%将用于一般企业及营运资金用途。(jl/w)~阿思达克财经新闻网址: www.aastocks.com</p></body></html>","source":"aastocks","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>《新股消息》3D MEDICINES-B(01244.HK)今起招股 一手入场费13,252.23元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n《新股消息》3D MEDICINES-B(01244.HK)今起招股 一手入场费13,252.23元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-29 08:27 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1229684&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0><strong>AAFN</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>生物医药公司3D MEDICINES-B(01244.HK)公布招股详情，拟全球发售1,635万股，香港公开发售占一成，国际发售占九成。招股价介乎每股22.96至26.24元。每手500股计，一手入场费13,252.23元。该股今日(11月29日)起招股，下周三(12月7日)中午截止，预期将于12月15日挂牌。联席保荐人为中金及中信建投国际。公司上市引入4名基石投资者，包括徐州经开区(香港)、...</p>\n\n<a href=\"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1229684&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LU0327786744.USD":"Janus Henderson Horizon China Opportunities A2 USD","LU1044876610.USD":"THREADNEEDLE (LUX) ASIAN CONTRARIAN EQUITY \"ZU\" (USD) ACC","LU1226287529.USD":"UBS (LUX) KEY SELECTION SICAV - CHINA ALLOCATION  OPPORTUNITY (USD) \"P\" (USD) ACC","LU1642822792.SGD":"THREADNEEDLE (LUX) ASIAN CONTRARIAN EQUITY \"A\" (SGD) ACC","LU0251144936.SGD":"Fidelity Sustainable Asia Equity A-SGD","LU0043850808.USD":"HSBC GIF ASIA EX JAPAN EQUITY \"AD\" INC","00388":"香港交易所","LU0873338254.USD":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"I\" (USD) INC","LU0577902611.USD":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"A\" (USD) ACC","LU0577902371.SGD":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"I\" (SGD) ACC","LU1044875133.USD":"天利亚洲反向股票 AU Acc","LU0456846285.SGD":"JPMorgan Funds - Greater China A (acc) SGD","LU1807302812.USD":"UBS (LUX) EQUITY SICAV ALL CHINA \"P\" (USD) ACC","LU0577902298.EUR":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"I\" (EUR) ACC","LU0140636845.USD":"施罗德大中华区股票A Acc","BK1589":"北水核心资产","LU0501845795.SGD":"瑞银大中华区股票基金P Acc SGD","LU0577902538.SGD":"Fullerton Lux Funds - Asia Growth and Income Equities A Acc SGD","LU0417516738.SGD":"Allianz Hong Kong Equity AT Acc SGD","BK1131":"金融交易所和数据","LU0348735423.USD":"ALLIANZ HONG KONG EQUITY \"A\" (USD) INC","LU0577902454.USD":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"I\" (USD) ACC","SG9999002463.SGD":"LionGlobal China Growth SGD","LU0072913022.USD":"UBS (LUX) EQUITY FUND -  GREATER CHINA \"P\" (USD) ACC","LU0048597586.USD":"富达亚洲焦点A","LU0211977185.USD":"EASTSPRING INVESTMENTS GREATER CHINA EQUITY \"A\" ACC","LU0572944931.SGD":"Janus Henderson Horizon China Opportunities A2 SGD","01244":"思路迪医药股份","LU0067412154.USD":"UBS (LUX) EQUITY FUND -  CHINA OPPORTUNITY \"P\" (USD) ACC","LU1044874839.SGD":"THREADNEEDLE (LUX) ASIAN CONTRARIAN EQUITY \"AGH\" (SGDHDG) ACC","SG9999004220.SGD":"Nikko AM Shenton Asia Dividend Equity Fund  SGD","LU2039709279.SGD":"MANULIFE GF DRAGON GROWTH \"AA\" (SGDHDG) INC","BK1521":"挪威政府全球养老基金持仓"},"source_url":"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1229684&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0","is_english":false,"share_image_url":"https://static.laohu8.com/51f6b9126f36f92bbf92982596066e5a","article_id":"2287545465","content_text":"生物医药公司3D MEDICINES-B(01244.HK)公布招股详情，拟全球发售1,635万股，香港公开发售占一成，国际发售占九成。招股价介乎每股22.96至26.24元。每手500股计，一手入场费13,252.23元。该股今日(11月29日)起招股，下周三(12月7日)中午截止，预期将于12月15日挂牌。联席保荐人为中金及中信建投国际。公司上市引入4名基石投资者，包括徐州经开区(香港)、Harvest、TradArt Investment SP及Mobilewise，合共认购2.35亿元公司股份。如以招股价中位数24.6元计，公司上市料净集资约2.45亿元，当中约90%主要用于产品和候选药物的研发、监管备案及商业化；约10%将用于一般企业及营运资金用途。(jl/w)~阿思达克财经新闻网址: www.aastocks.com","news_type":1},"isVote":1,"tweetType":1,"viewCount":251,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":2,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}